Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00291096 · ClinicalTrials.gov registry record
High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast Cancer
A clinical trial of Breast Cancer, sponsored by Carol Fabian, MD.
- Recruiting
- Registry status
- 3,000
- Enrollment target
- 1
- Study location
NCT00291096: Recruiting study of Breast Cancer, sponsored by Carol Fabian, MD.
NCT00291096 is a study of Breast Cancer that is actively recruiting participants, run by Carol Fabian, MD. The registered enrollment target is 3,000 participants, roughly in line with the 2,801-participant average among 1,224 other Breast Cancer trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00291096, a study of Breast Cancer, is actively recruiting participants, sponsored by Carol Fabian, MD.
- RECRUITING
- Registry status
- 3,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall goal of this project is to develop an integrative system of breast cancer risk assessment based on epidemiologic and biologic risk variables, as well as to develop or refine risk biomarkers which may be useful in predicting and monitoring response to prevention interventions.
Primary Outcome
development of algorithm for predicting risk for developing breast cancer based on random sampling of benign breast tissue.
Conditions Studied
Study Locations (1)
Kansas
- University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 1989-08 |
| Est. Completion | 2027-12 |
What NCT00291096 shows while recruiting
NCT00291096 is an observational study that tracks outcomes without assigning an intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 2,801-participant average among 1,224 other Breast Cancer trials with a reported enrollment target.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT00291096 reports a single indexed study location in Kansas.
Frequently Asked Questions
What is clinical trial NCT00291096 about?
NCT00291096 is a clinical study titled "High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast Cancer". The overall goal of this project is to develop an integrative system of breast cancer risk assessment based on epidemiologic and biologic risk variables, as well as to develop or refine risk biomarkers which may be useful in predicting and monitoring response to prevention interventions.
What is the current status of trial NCT00291096?
This trial is currently recruiting. The enrollment target is 3,000 participants. The study started on 1989-08. Estimated completion is 2027-12.
What conditions does trial NCT00291096 study?
This clinical trial studies the following conditions: Breast Cancer.
Who is sponsoring clinical trial NCT00291096?
This trial is sponsored by Carol Fabian, MD, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00291096 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00291096's enrollment target sits among peer trials
3,000 51st of 1224 higher than 1,174 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia